Hareid, Jonathan A.2013-08-272013-08-272006-05Minnesota Journal of Law, Science & Technology, Volume 7, Issue 2 (May 2006), pages 713-756.1552-9541https://hdl.handle.net/11299/155981enTesting Drugs and Testing Limits: Merck KGaA v. Integra Lifesciences I, Ltd. and the Scope of the Hatch-Waxman Safe Harbor ProvisionArticle